NDAORALCAPSULE
Approved
Aug 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
ESCITALOPRAM (escitalopram) by Almatica Pharma is escitalopram, the s-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (cns) resulting from its inhibition of cns neuronal reuptake of serotonin (5-ht). Approved for major depressive disorder, generalized anxiety disorder. First approved in 2025.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Escitalopram is the S-enantiomer of citalopram, an oral selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder and generalized anxiety disorder. It works by inhibiting CNS neuronal reuptake of serotonin (5-HT), potentiating serotonergic activity in the central nervous system. Almatica Pharma's escitalopram capsule formulation recently launched in August 2025, entering a mature competitive market.
Launch
Early-stage launch product with moderate competitive pressure (30%) indicates active commercial buildout phase; launch teams will focus on differentiation and market penetration.
Mechanism of Action
escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Indications (2)
Worked on ESCITALOPRAM at Almatica Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.